Getting stroke patients
to the right hospital
for the right treatment
as fast as possible

TrianecT develops the next revolution in pre-hospital stroke care

Accurate

Fast

Portable

The problem

Each year, 10 million severe stroke patients are picked up by ambulances around the world. Half of these stroke patients that can be treated with endovascular treatment, but are brought to hospitals that do not have endovascular treatment. This results in an average delay of endovascular treatment of 90 minutes, which leads to seriously worsened disease outcomes and a larger burden on society.

Our solution

With StrokePointer from TrianecT, we combine brain activity measurement and artificial intelligence to detect these treatable stroke patients in the ambulance and bring them directly to their best treatment. This saves time and time = brain.

Our Team

Dr. Wouter Potters

CEO, Co-founder

Dr. Jonathan Coutinho

Co-founder

Dr. Henk Marquering

Co-founder

Frank Zanow

Dr. Frank Zanow

Co-founder

Pascal Binnekamp

Algorithm developer

Simon van Bezooijen

Application developer

Amin Azouagh

Marketing Strategist 

You?


apply now

Our partners

AMC Ventures Holding Logo

2018

Amsterdam Science & Innovation Award

2021

First clinical trial results

2022

TrianecT incorporated

Do you want to join our mission to improve acute stroke care?

Then connect with us at letsmeet@trianect.com

    Careers

    Are you a talented and self-driven student looking for an internship? Do you want to take on a challenge  in our young and dynamic start-up? We welcome internship applications of excellent candidates (for example on marketing, sales, medical software development or UX design). Make sure to attach your curriculum vitae and your motivation letter when applying.

    Apply at internship@trianect.com